Skip to main content

S-100 Proteins

  • Living reference work entry
  • First Online:
Encyclopedia of Cancer
  • 63 Accesses

S100 Proteins

S100, S100B, S100P, S100A1, S100A2, S100A3, S100A4, S100A7, S100A8/9, S100A10, S100A11, S100A13.

Definition

S100 proteins are small molecular weight calcium-binding proteins with two calcium-binding domains made up of two helix-loop-helix (EF-hand) motifs. Also, S100 proteins are subcellular fractions of proteins which are completely (100 %) solubilized at neutral pH of saturated ammonium sulfate, hence the name S100. They are known to be highly similar in their structure and amino acid sequences but are quite different in their functions. So far, there are 21 members of the S100 family in the human genome. These proteins are often metabolized in the kidney and released in urine with a half-life of ~2 h.

Characteristics

Members of S100 protein family play a significant role in progression and metastasis of various cancers. Majority of S100 proteins are exclusively present on human chromosome 1q21, the epidermal differentiation complex (EDC) region. This region has high...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Abbreviations

AKT:

Protein kinase B

BCL2:

B-cell lymphoma 2

CCL2:

Chemokine CC ligand 2

CREB:

Camp response element-binding protein

DLC1:

Deleted in liver cancer 1

EGF:

Epithelial growth factor

EMT:

Epithelial mesenchymal transduction

ERK:

Extracellular regulated kinases

ESCC:

Esophageal squamous cell carcinoma

FGF-1:

Fibroblast growth factor 1

IDC:

Invasive ductal carcinaoma

Jab1:

c-Jun activation domain-binding protein-1

KLF:

Kruppel-like factor

miR155:

MicroRNA 155

miR29b:

MicroRNA 29b

MMP9:

Metalloproteinase 9

MMTV:

Mouse mammary tumor virus.

Ndr:

Nuclear Dbf2-related kinase

NF-κB:

Nuclear factor-kappa B

OSCC:

Oral squamous cell carcinoma

PI3K:

Phosphatidylinositide 3-kinases

PyMT:

Polyoma middle T-antigen

RAGE:

Receptor for advanced glycation end product

ROS:

Reactive oxygen species

SP:

Sp transcription factor

STAT:

Signal transducer and activator of transcription

Stat3:

Signal transducer and activator of transcription 3

TAMs:

Tyro-3 Axl, and Mer tyrosine kinase receptors

TGF-β:

Transforming growth factor beta

TLR4:

Toll like receptor 4

TNF:

Tumor necrosis factor

VEGF:

Vascular endothelial growth factor

References

  • Boye K, Maelandsmo GM (2010) S100A4 and metastasis: a small actor playing many roles. Am J Pathol 176(2):528–535

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bresnick AR, Weber DJ, Zimmer DB (2015) S100 proteins in cancer. Nat Rev Cancer 15(2):96–109

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen H, Xu C, Jin Q, Liu Z (2014) S100 protein family in human cancer. Am J Cancer Res 4(2):89–115

    PubMed  PubMed Central  Google Scholar 

  • Donato R (2001) S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33(7):637–668

    Article  CAS  PubMed  Google Scholar 

  • Drews-Elger K, Iorns E, Dias A et al (2014) Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcome. Breast Cancer Res Treat 148(1):41–59

    Article  CAS  PubMed  Google Scholar 

  • Emberley ED, Murphy LC, Watson PH (2004) S100 proteins and their influence on pro-survival pathways in cancer. Biochem Cell Biol 82(4):508–515

    Article  CAS  PubMed  Google Scholar 

  • Foell D, Wittkowski H, Vogl T, Roth J (2007) S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol 81(1):28–37

    Article  CAS  PubMed  Google Scholar 

  • Grum-Schwensen B, Klingelhöfer J, Grigorian M et al (2010) Lung metastasis fails in MMTV-PyMT oncomice lacking S100A4 due to a T-cell deficiency in primary tumors. Cancer Res 70(3):936–947

    Article  CAS  PubMed  Google Scholar 

  • Hiratsuka S, Watanabe A, Sakurai Y et al (2008) The S100A8–serum amyloid A3–TLR4 paracrine cascade establishes a pre-metastatic phase. Nat Cell Biol 10(11):1349–1355

    Article  CAS  PubMed  Google Scholar 

  • Nasser MW, Qamri Z, Deol YS et al (2012) S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways. Cancer Res 72(3):604–615

    Article  CAS  PubMed  Google Scholar 

  • Nasser MW, Wani N, Ahirwar DK et al (2015) RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironment. Cancer Res 75:974

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Salama I, Malone PS, Mihaimeed F, Jones JL (2008) A review of the S100 proteins in cancer. Eur J Surg Oncol 34(4):357–364

    Article  CAS  PubMed  Google Scholar 

  • Zhao H, Wilkie T, Deol Y et al (2015) miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer. Mol Cancer 14(1):11

    Article  CAS  PubMed  PubMed Central  Google Scholar 

See Also

  • (2012) Astrocyte. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 297. doi:10.1007/978-3-642-16483-5_422

    Google Scholar 

  • (2012) Bone sarcomas. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 446. doi:10.1007/978-3-642-16483-5_685

    Google Scholar 

  • (2012) Cancer of the large intestine. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 626. doi:10.1007/978-3-642-16483-5_810

    Google Scholar 

  • (2012) Cell cycle. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 737. doi:10.1007/978-3-642-16483-5_994

    Google Scholar 

  • (2012) Cell cycle arrest. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 737. doi:10.1007/978-3-642-16483-5_995

    Google Scholar 

  • (2012) Colorectal cancer. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 916. doi:10.1007/978-3-642-16483-5_1265

    Google Scholar 

  • (2012) COX-2. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 989. doi:10.1007/978-3-642-16483-5_1355

    Google Scholar 

  • (2012) EGF. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 1211. doi:10.1007/978-3-642-16483-5_1824

    Google Scholar 

  • (2012) ERK. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, pp 1307–1308. doi:10.1007/978-3-642-16483-5_1987

    Google Scholar 

  • (2012) Genetically engineered mice. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 1532. doi:10.1007/978-3-642-16483-5_2386

    Google Scholar 

  • (2012) Immune system. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 1815. doi:10.1007/978-3-642-16483-5_2980

    Google Scholar 

  • (2012) Laryngeal cancer. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 1981. doi:10.1007/978-3-642-16483-5_6476

    Google Scholar 

  • (2012) Orthotopic model. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 2661. doi:10.1007/978-3-642-16483-5_4265

    Google Scholar 

  • (2012) P53. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 2747. doi:10.1007/978-3-642-16483-5_4331

    Google Scholar 

  • (2012) Proliferation. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3004. doi:10.1007/978-3-642-16483-5_4766

    Google Scholar 

  • (2012) Promoter. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3004. doi:10.1007/978-3-642-16483-5_4768

    Google Scholar 

  • (2012) Prostate cancer. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, pp 3009–3010. doi:10.1007/978-3-642-16483-5_6576

    Google Scholar 

  • (2012) RAGE. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3163. doi:10.1007/978-3-642-16483-5_4939

    Google Scholar 

  • (2012) SMAD. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3440. doi:10.1007/978-3-642-16483-5_5360

    Google Scholar 

  • (2012) Sp. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3471. doi:10.1007/978-3-642-16483-5_5426

    Google Scholar 

  • (2012) STAT. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3502. doi:10.1007/978-3-642-16483-5_5481

    Google Scholar 

  • (2012) TNF-a. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3713. doi:10.1007/978-3-642-16483-5_5841

    Google Scholar 

  • (2012) Tumorigenesis. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3815. doi:10.1007/978-3-642-16483-5_6063

    Google Scholar 

  • (2012) Tumor suppressor. In: Schwab M (ed) Encyclopedia of cancer, 3rd edn. Springer, Berlin/Heidelberg, p 3803. doi:10.1007/978-3-642-16483-5_6056

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mohd W. Nasser .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg (outside the USA)

About this entry

Cite this entry

Elbaz, M., Amponsah, G., Ganju, R.K., Nasser, M.W. (2015). S-100 Proteins. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27841-9_5143-2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-27841-9_5143-2

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-27841-9

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics